Case report of a renal cell carcinoma patient with acute pancreatitis under both sunitinib and axitinib treatment

Sunitinib and axitinib are oral tyrosine kinase inhibitors (TKI) that is commonly used in the treatment of metastatic renal cell carcinoma (RCC) as it has been shown to improve the progression-free survival of patients compared with sorafenib. Hypertension, palmar-plantar erythrodysesthesia, diarrhe...

Full description

Bibliographic Details

Published in:	Journal of Oncological Sciences
Main Authors:	Utku Oflazoglu, Umut Varol, Ahmet Alacacioglu, Tarik Salman, Necla Demir, Huseyin Salih Semiz, Aziz Karaoglu, Ilhan Oztop
Format:	Article
Language:	English
Published:	Turkish Society of Oncology 2016-08-01
Subjects:	Sunitinib Axitinib Renal cell carcinoma Pancreatitis Side effects
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452336416300267